Skip Navigation


Annals of Oncology Advance Access originally published online on April 8, 2005
Annals of Oncology 2005 16(6):863-868; doi:10.1093/annonc/mdi175
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow CME/CE:
Take the course for this article:
 Annals of Oncology course: part 2 iss...
Right arrow All Versions of this Article:
16/6/863    most recent
mdi175v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoei-Hansen, C. E.
Right arrow Articles by Skakkebaek, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoei-Hansen, C. E.
Right arrow Articles by Skakkebaek, N. E.
Related Collections
Right arrow 2005 - Review Articles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Review

Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review

C. E. Hoei-Hansen1,*, E. Rajpert-De Meyts1, G. Daugaard2 and N. E. Skakkebaek1

University Departments of 1Growth and Reproduction and 2 Oncology, Rigshospitalet, Copenhagen, Denmark

* Correspondence to: Dr C. E. Hoei-Hansen, University Department of Growth and Reproduction (GR5064), Rigshospitalet Blegdamsvej 9, DK2100 Copenhagen, Denmark. Tel: +45-35-45-50-64; Fax: +45-35-45-60-54; Email: chh{at}dadlnet.dk

Testicular germ cell tumours (TGCT), including seminomas, embryonal carcinomas, teratomas and yolk sac tumours, have a common precursor, the carcinoma in situ (CIS) cell. Recent gene expression studies displaying close similarity of CIS cells to embryonic stem cells support the longstanding theory that CIS most likely originates in utero from fetal gonocytes. The clinical association between the testicular dysgenesis syndrome components (TGCT, cryptorchidism, genital malformations, some forms of decreased spermatogenesis) also implies a prenatal origin. Despite high cure rates of TGCT, efforts should be made to obtain diagnosis at the CIS stage, as intervention is possible before an invasive tumour develops, thus reducing the necessity for intensive therapy. CIS may be suspected in patients with an assumed extragonadal GCT or cryptorchidism, and in intersex patients and selected cases with infertility (presenting with atrophic testes and ultrasonic microlithiasis). Surgical testicular biopsy seems the only reliable diagnostic method. The management of choice of unilateral CIS is orchidectomy, or localised irradiation in bilateral cases. At least 5% of TGCT patients present with contralateral CIS; therefore, contralateral biopsy is recommended at the time of orchidectomy. Further research is warranted to identify causal factors explaining the increasing incidence of TGCT and to obtain a method of non-invasive CIS detection.

Key words: intratubular germ cell neoplasia, unclassified type, testicular cancer, testicular dysgenesis syndrome, testicular intraepithelial neoplasia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
C. M. Spiller, D. Wilhelm, and P. Koopman
Retinoblastoma 1 Protein Modulates XY Germ Cell Entry into G1/G0 Arrest During Fetal Development in Mice
Biol Reprod, February 1, 2010; 82(2): 433 - 443.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Abdulhadi-Atwan, A. Jean, W. K. Chung, K. Meir, Z. Ben Neriah, G. Stratigopoulos, S. E. Oberfield, I. Fennoy, H. J. Hirsch, A. Bhangoo, et al.
Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4000 - 4008.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
O. Khan and A. Protheroe
Testis cancer
Postgrad. Med. J., October 1, 2007; 83(984): 624 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.I. McLachlan, E. Rajpert-De Meyts, C.E. Hoei-Hansen, D.M. de Kretser, and N.E. Skakkebaek
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: Mini Review
Hum. Reprod., January 1, 2007; 22(1): 2 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C.E. Hoei-Hansen, E. Carlsen, N. Jorgensen, H. Leffers, N.E. Skakkebaek, and E. Rajpert-De Meyts
Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers
Hum. Reprod., January 1, 2007; 22(1): 167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Ferrara, N. Hallmark, H. Scott, R. Brown, C. McKinnell, I. K. Mahood, and R. M. Sharpe
Acute and Long-Term Effects of in Utero Exposure of Rats to Di(n-Butyl) Phthalate on Testicular Germ Cell Development and Proliferation
Endocrinology, November 1, 2006; 147(11): 5352 - 5362.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.